Incomplete and inconsistent capture of information about race and ethnicity in real-world data (RWD) limits a full understanding of the distribution, safety, and effectiveness of FDA-regulated products, which impacts the health of the public.

The Reagan-Udall Foundation for the FDA, in collaboration with FDA's Office of Minority Health and Health Equity, launched RAISE to elevate the capture and curation of race and ethnicity data in health care settings to ultimately improve the quality of health care and medical products.

Speaker bios

AGENDA

Welcome 
        Speaker: Susan C. Winckler RPh, Esq, Reagan-Udall Foundation for the FDA

Welcome Remarks from FDA
        Speaker: RDML Richardae Araojo, PharmD, MS, U.S. Food and Drug Administration
                       

Connecting the Dots
        Speaker: Carla Rodriguez-Watson, PhD, MPH, Reagan-Udall Foundation for the FDA

Presentations 

       Imputation of Race and Ethnicity Categories in RWD from Genetic Ancestry
       Francisco De La Vega, DSc
       Vice President of Hereditary Disease
       Tempus         

       Statistical Methods for Measuring Health Disparities in the Population 
       Ali Mokdad, PhD
       Professor, Chief Strategy Officer of Population Health, Associate Chair for Collaboration
       Associate Chair for Equity
       University of Washington

       Genomics for Everyone? Considerations for Equity and Benefit-Sharing for Indigenous Peoples
       Krystal Tsosie, PhD, MPH, MA
       Indigenous Geneticist-Bioethicist
       Assistant Professor
       School of Life Sciences, Arizona State University

Moderated Discussion 
         Moderator: Phil Febbo, MD 
                           Chief Medical Officer
                           Illumina

          Discussants:
          Francisco De La Vega, DSc
          Ali Mokdad, PhD
          Krystal Tsosie, PhD, MPH, MA

Adjourn